Pages that link to "Q45260565"
Jump to navigation
Jump to search
The following pages link to A clinical trial of adjuvant allopurinol therapy for moderately refractory schizophrenia (Q45260565):
Displaying 10 items.
- Guanosine: a Neuromodulator with Therapeutic Potential in Brain Disorders (Q28072158) (← links)
- Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy (Q30457808) (← links)
- A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania (Q34595181) (← links)
- Reduced striatal ecto-nucleotidase activity in schizophrenia patients supports the "adenosine hypothesis". (Q37468669) (← links)
- Clinical potential of allopurinol in the treatment of bipolar disorder (Q39887772) (← links)
- Anti-nociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1 adenosine receptors (Q41422598) (← links)
- Purinergic system in psychiatric diseases. (Q47758170) (← links)
- Cell-subtype-specific changes in adenosine pathways in schizophrenia. (Q52684296) (← links)
- Comparative metabolome analysis of serum changes in sheep under overgrazing or light grazing conditions (Q92263258) (← links)
- Galantamine-Memantine Combination as an Antioxidant Treatment for Schizophrenia (Q96817727) (← links)